Has Todd Ruth, MD received payments from drug or device companies?

Yes. Drug and device makers reported $20,183 in general payments to Todd Ruth, MD across 663 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Todd Ruth, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Todd Ruth, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Todd Ruth, MD

Interventional Pain Medicine · Baltimore, MDNPI 1437569779

Payments from drug & device makers

$20,183in general payments, 2019–2025

Across 663 payments — averaging $30.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Nevro Corp.$12K
AbbVie$1K
Abbott$993
Globus Medical$960
Vertos Medical, Inc.$728
Medtronic$686
plus $4K from 43 others

What the payments were for

Speaking & faculty fees$4,54523%
Travel & lodging$2701%
Food & beverage$15,36876%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Nevro Corp.	257	$11,771
AbbVie(2 entities)	75	$1,203
Abbott	26	$993
Globus Medical	34	$960
Vertos Medical, Inc.	43	$728
Medtronic(2 entities)	29	$686
Boston Scientific	21	$456
Collegium Pharmaceutical, Inc.	21	$382
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	28	$349
Teva Pharmaceuticals USA, Inc.	13	$233
Electronic Waveform Lab, Inc.	9	$200
Saluda Medical Americas, Inc.	10	$182
Amgen(2 entities)	7	$167
GRT US Holding, Inc.	8	$160
Biohaven Pharmaceutical Holding Company Ltd.	8	$156
Pfizer	7	$134
Foundation Fusion Solutions, LLC	1	$125
Biotronik NRO, Inc.	5	$107
Scilex Pharmaceuticals Inc.	7	$101
Biohaven Pharmaceuticals, Inc.	5	$99
Lundbeck LLC	4	$89
Lilly USA, LLC	4	$62
Tonix Medicines, Inc.	2	$56
Akcea Therapeutics, Inc.	2	$55
Vertex	3	$54
Averitas Pharma Inc.	2	$53
Johnson & Johnson	2	$53
Almatica Pharma LLC	2	$44
Relievant Medsystems, Inc.	1	$42
Stryker	2	$38
Redhill Biopharma Inc.	2	$36
Biodelivery Sciences International, Inc.	3	$35
Interventional Pain Technologies Inc.	1	$32
Si-bone, Inc.	1	$32
Sanofi-aventis U.S. LLC	2	$32
Arbor Pharmaceuticals, Inc.	2	$31
International Rehabilitative Sciences, Inc	2	$29
Forte Bio-pharma LLC	1	$28
Spinal Simplicity, LLC	1	$25
Sanara Medtech Inc.	1	$22
Convatec Inc.	1	$22
Zavation Medical Products, LLC	1	$20
Protega Pharmaceutials Inc	1	$19
Sentynl Therapeutics, Inc.	1	$17
Curonix LLC	1	$17
Fidia Pharma USA Inc.	1	$16
Zyla Life Sciences, Inc.	1	$14
Kowa Pharmaceuticals America, Inc.	1	$13
SPR Therapeutics, Inc	1	$11

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Omnia$5,466
Senza Spinal Cord Stimulation System$1,041
Senza$550
Proclaim Family of SCS IPGs$367
INTELLIS$126
Penta SCS Leads$106

How this compares

$20,183 in reported general payments places this provider in the 80th percentile of 56 interventional pain medicine providers in Maryland.

See all interventional pain medicine providers in Maryland →

Medicare billing

Part B allowed, 2024

$645,390

Medicare patients

589

Services billed

4,848

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
OxycontinOxycodone Hcl	15	$9,115
Oxycodone Hcl	390	$6,513
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	186	$4,739
Gabapentin	203	$3,161
Pregabalin	117	$3,036
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	132	$2,872
Tizanidine Hcl	277	$2,754
Morphine Sulfate ErMorphine Sulfate	112	$2,640
Naloxone Hcl	38	$2,543
Tramadol Hcl	217	$2,068
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl	21	$1,907
Duloxetine Hcl	103	$1,546
Cyclobenzaprine Hcl	103	$1,021
Hydromorphone Hcl	39	$488
Carisoprodol	37	$484

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Baltimore

Dontese NicholsonBaltimore$27K
Srinivasa RajaBaltimore$18K
Bradford WintersBaltimore$4K
Michael GardynBaltimore$2K
Eric JacksonBaltimore$2K
Harrison LinderBaltimore$1K
Kayode WilliamsBaltimore$587
Matthew HansenBaltimore$580
Mark ColemanPikesville$1.3M
Marc LoevRockville$318K

See the full list for Maryland →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →